Hospira plans to complete offer

LAKE FOREST - Hospira Inc., a global specialty pharmaceutical and medication delivery company, announced its intention to complete the tender offer by Discus Acquisition Corp., a wholly owned Hospira subsidiary, for all outstanding shares of the common stock of Javelin Pharmaceuticals Inc. Javelin notified Hospira that it will deliver a closing certificate in accordance with the merger agreement among the parties, confirming the accuracy of its representations and warranties as of the end of the current offer period.